[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340697-105":59,"doc-detail-340697-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","steap3-is-a-potential-preliminary-prognostic-biomarker-of-glioblastoma","STEAP3 is a potential preliminary prognostic biomarker of glioblastoma","","STEAP3, an iron-regulation protein family member, is assessed as a prognostic biomarker for glioblastoma (GB) using mRNA expression profiles from GEO and TCGA as validation and training cohorts. Higher STEAP3 expression correlates with worse overall survival across cohorts. STEAP3-associated genes show enrichment in leukocyte migration, JAK-STAT signaling, and cytokine-mediated pathways. In the STEAP3 high-expression group, ESTIMATE, ImmuneScore, StromalScore, and immunophenoscore rise, suggesting effects on the tumor microenvironment and potential influence on GB metastasis and immunotherapy response.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/steap3-is-a-potential-preliminary-prognostic-biomarker-of-glioblastoma/340697/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/steap3-is-a-potential-preliminary-prognostic-biomarker-of-glioblastoma/340697.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study regarding STEAP3 and glioblastoma?","Question",{"text":112,"@type":113},"To evaluate whether STEAP3 has prognostic value in glioblastoma by analyzing expression patterns and their association with survival and tumor microenvironment features.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were training and validation cohorts obtained?",{"text":117,"@type":113},"mRNA expression profiles from TCGA were used as the training cohort, while external validation utilized GEO datasets, including GSE108474.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship did the study find between STEAP3 expression and patient outcomes?",{"text":121,"@type":113},"Higher STEAP3 expression was associated with shorter overall survival in glioblastoma patients across the analyzed cohorts.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340697,1790948317,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSTEAP3 is a potential preliminary prognostic biomarker of glioblastoma  \nWenhua Zhang1, Meng Xie2, Qiang Huang3, Honglei Liu1, Jianfeng Liu1, Xiaoli Sun1􀀍 & Conghui Li1􀀍  \nSix-transmembrane epithelial antigen of prostate 3 (STEAP3), a member of the iron regulation protein family, is characterized by a high recurrence rate and a short survival time. Nevertheless, studies investigating the role of STEAP3 in glioblastoma (GB) are scarce. In this study, the prognostic value of STEAP3 was evaluated utilizing mRNA expression profiles from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases as the validation and training cohorts, respectively. Moreover, differentially expressed genes were subjected to a functional enrichment analysis. The relationship between STEAP3 and the tumor microenvironment (TME) was examined. The immunophenoscore (IPS) and tumor immune dysfunction and exclusion (TIDE) score were used to investigate response to immunotherapy. In all cohorts, GB patients with higher STEAP3 expression levels exhibited shorter overall survival (OS). Additionally, STEAP3-associated genes were primarily implicated in leukocyte migration, the JAK-STAT signaling pathway, and the cytokine-mediated signaling pathway. In the STEAP3 high-expression group, the ESTIMATEScore, ImmuneScore, StromalScore, and IPS were significantly higher. Overall, our results highlighted that STEAP3 might serve as a candidate prognostic biomarker for GB. Additionally, it might regulate the TME and influence GB metastasis.  \nKeywords STEAP3, Glioblastoma, Prognosis, Tumor immunity  \nGB is a particularly aggressive and lethal form of brain cancer that primarily affects adults. Infiltration and relapse, which have been hypothesized to be connected to epithelial-mesenchymal transition and the development of stem cell-like characteristics, including self-renewal and invasiveness1, remain chief therapeutic challenges in GB treatment2. Of note, GB recurrence enhances its invasiveness and aggressiveness, as well as promotes tumor progression. Earlier studies have identified chromosome 1p/19q co-deletion and isoketone dehydrogenase (IDH) mutations as molecular pathological indicators in gliomas, which have been associated with improved survival outcomes3,4 Thus, there is an urgent need to identify novel therapeutic molecular targets and pathways that could exploit the vulnerabilities of GB.  \nAs key regulators of metal homeostasis, the four members of the six-transmembrane epithelial antigen of the prostate (STEAP) protein family play a pivotal role in several diseases5. In human malignant tumors, such as brain, bladder, and breast cancer, dysregulation of the STEAP family proteins drives the growth, migration, and malignant transformation of tumor cells, leading to a high recurrence rate and shorter survival times6–10. On chromosome 2q14.2, STEAP3 functions as a ferrireductase that facilitates iron absorption by converting ferric iron to ferrous iron in endosomes11. Iron-dependent phospholipid peroxidation on cellular membranes drives ferroptosis, a controlled mechanism of cell death closely associated with dysregulation of iron metabolism12. According to previous studies, the STEAP3 promoter contains a p53-binding site and can up-regulate p53 expression to trigger breast cancer cell death13. Furthermore, considering that inducers offerroptosis can affect mesenchymal tumor cells, which are associated with resistance to conventional treatments14, they may represent potential therapeutic targets in the treatment of cancers. Previous research has indicated that gliomas displayed elevated STEAP3 expression levels. Nevertheless, studies exploring the predictive utility of STEAP3 for GB are limited.  \nIn the present research, the correlations between STEAP3 and tumor-infiltrating immune cells and response to immunotherapy, as well as the prognostic value of STEAP3 in GB, ","cbCaifbOmjeotup9","https://ap.wps.com/l/cbCaifbOmjeotup9","pdf",3023287,16,"English","# Methods and materials\n## Data collection and figure generation\n## STEAP3’s roles and expression in Pan-cancer","[{\"question\":\"What is the main purpose of the study regarding STEAP3 and glioblastoma?\",\"answer\":\"To evaluate whether STEAP3 has prognostic value in glioblastoma by analyzing expression patterns and their association with survival and tumor microenvironment features.\"},{\"question\":\"How were training and validation cohorts obtained?\",\"answer\":\"mRNA expression profiles from TCGA were used as the training cohort, while external validation utilized GEO datasets, including GSE108474.\"},{\"question\":\"What relationship did the study find between STEAP3 expression and patient outcomes?\",\"answer\":\"Higher STEAP3 expression was associated with shorter overall survival in glioblastoma patients across the analyzed cohorts.\"}]","STEAP3 is a potential preliminary prognostic biomarker of glioblastoma | PDF",1790038330,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6b86d47fc5a475673dab9fda72557c9.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7d474a60282c95ff26aeae7ab16f858.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9e76ef1cf82285090f324ed98a9a720.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae3ca1748608c30a3fae2d32b8406bcf.webp",980,1287]